Overview
Lijun Wen practices in Suzhou, China. Wen is rated as a Distinguished expert by MediFind in the treatment of Acute Promyelocytic Leukemia. Their top areas of expertise are Acute Promyelocytic Leukemia, Acute Myeloid Leukemia (AML), Philadelphia-Negative Chronic Myeloid Leukemia, Leukemia, and Bone Marrow Transplant.
Their clinical research consists of co-authoring 50 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 14 articles in the study of Acute Promyelocytic Leukemia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Promyelocytic LeukemiaWen isDistinguished. Learn about Acute Promyelocytic Leukemia.
- Advanced
- Acute Myeloid Leukemia (AML)
- LeukemiaWen isAdvanced. Learn about Leukemia.
- Philadelphia-Negative Chronic Myeloid Leukemia
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- Bone Marrow TransplantWen isExperienced. Learn about Bone Marrow Transplant.
- Chromosome 8p DeletionWen isExperienced. Learn about Chromosome 8p Deletion.
- Chronic Myelogenous Leukemia (CML)
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Mosaic Trisomy 8Wen isExperienced. Learn about Mosaic Trisomy 8.